The estimated Net Worth of Warren L. De Souza is at least $1.01 million dollars as of 3 April 2017. Warren Souza owns over 15,000 units of Aimmune Therapeutics Inc stock worth over $1,013,340 and over the last 9 years Warren sold AIMT stock worth over $0.
Sign up
Warren Souza AIMT stock SEC Form 4 insiders trading
Warren has made over 3 trades of the Aimmune Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Warren exercised 15,000 units of AIMT stock worth $45,300 on 3 April 2017.
The largest trade Warren's ever made was exercising 20,681 units of Aimmune Therapeutics Inc stock on 11 January 2017 worth over $62,457. On average, Warren trades about 9,136 units every 16 days since 2016. As of 3 April 2017 Warren still owns at least 35,681 units of Aimmune Therapeutics Inc stock.
You can see the complete history of Warren Souza stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Warren Souza's mailing address?
Warren's mailing address filed with the SEC is 8000 Marina Blvd #200, Brisbane, CA 94005, USA.
Insiders trading at Aimmune Therapeutics Inc
Over the last 9 years, insiders at Aimmune Therapeutics Inc have traded over $19,285,948 worth of Aimmune Therapeutics Inc stock and bought 61,698,079 units worth $2,225,231,200 . The most active insiders traders include Des Produits Nestle S.A. So..., Patrick G Enright et Des Produits Nestle S.A.Nes.... On average, Aimmune Therapeutics Inc executives and independent directors trade stock every 22 days with the average trade being worth of $21,038,606. The most recent stock trade was executed by Des Produits Nestle S.A. So... on 13 October 2020, trading 54,117,287 units of AIMT stock currently worth $1,867,046,402.
What does Aimmune Therapeutics Inc's logo look like?
Complete history of Warren Souza stock trades at Aimmune Therapeutics Inc
Aimmune Therapeutics Inc executives and stock owners
Aimmune Therapeutics Inc executives and other stock owners filed with the SEC include:
-
Stacey Denenberg Seltzer,
Director -
Jeffrey H Knapp,
Chief Operating Officer -
Susan E. Barrowcliffe,
General Manager, Europe -
Capital Partners Ii, Llc Ta...,
-
Kathryn E Falberg,
Director -
Daniel C Md Adelman,
Chief Medical Officer -
Mary M. Rozenman,
See Remarks -
Capital Management Ii, Llc ...,
-
Capital Partners Ii, Llc Lo...,
-
Gregory Behar,
Director -
Douglas T. Sheehy,
See Remarks -
Mark T Iwicki,
Director -
Eric Bjerkholt,
Chief Financial Officer -
Mark Mcdade,
Director -
Warren L. De Souza,
Chief Financial Officer -
Robert Myles Elfont,
Chief Medical Officer -
Jayson Donald Alexander Dallas,
President and CEO -
Health Science Us Holdings,...,
-
Des Produits Nestle S.A.Nes...,
-
Bakker Juliet Tammenoms,
10% owner -
Stephen George Dilly,
See Remarks -
Andrew Oxtoby,
Chief Commercial Officer -
Capital Partners Ii, Llc Ta...,
-
Patrick G Enright,
Director -
Brett K Haumann,
Director -
Des Produits Nestle S.A. So...,
10% owner